Publication: Persistent de Quervain tenosynovitis induced by somatotropin treatment
Loading...
Program
relationships.isAuthorOf
Author
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Background: Growth hormone deficiency is a well-known clinical entity that is usually treated with somatotropin (growth hormone). Growth hormone has some frequent side effects such as intracranial hypertension, lymphedema and diabetes mellitus.
Description
Source
Keywords
Keywords
Citation
Yurdakul O. V. , Ayture L., YALCINKAYA E. Y. , -Persistent de Quervain tenosynovitis induced by somatotropin treatment-, JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.30, ss.1223-1226, 2017